论文部分内容阅读
目的观察吲达帕胺联合氨氯地平治疗高血压合并冠心病的临床效果。方法选择医院收治的高血压合并冠心病136例,随机分为观察组和对照组,每组68例。对照组予以硝苯地平控释片,观察组予以吲达帕胺联合氨氯地平治疗。观察2组临床疗效及血压、血脂水平。结果观察组治疗总有效率为89.7%,高于对照组的72.1%(P<0.05);治疗后,观察组血压和血脂均低于对照组(P<0.01)。结论吲达帕胺联合氨氯地平治疗高血压合并冠心病临床疗效较好。
Objective To observe the clinical effect of indapamide combined with amlodipine in the treatment of hypertension and coronary heart disease. Methods A total of 136 patients with hypertension and coronary heart disease admitted to the hospital were randomly divided into observation group and control group, with 68 cases in each group. The control group was given nifedipine controlled release tablets, the observation group was treated with indapamide combined with amlodipine. The clinical efficacy, blood pressure and blood lipid level in the two groups were observed. Results The total effective rate in the observation group was 89.7%, which was higher than that in the control group (72.1%, P <0.05). After treatment, the blood pressure and blood lipids in the observation group were lower than those in the control group (P <0.01). Conclusion Indapamide combined with amlodipine in the treatment of hypertension with coronary heart disease clinical efficacy is better.